In comparison to curcumin or Cisplatin alone, co-treatment with curcumin (10 μM) and cisplatin (10 μM) has demonstrated a strong synergistic effect by up-regulating ERK1/2 phosphorylation and activating Caspase-3 in bladder cancer cell lines [385]. This evidence concerns the gene CASP3 and urinary bladder cancer.